Table 3: Comparison of clinical and metabolic characteristics of responders and non-responders before and after treatment.

Adjusted for age and gender; Data shown as mean ± standard division;
HDL-C: high-density lipoprotein-cholesterol.
NS= : non-significant, responders v.s. non-responders.
a responders v.s. non-responders.
b p<0.05 before treatment v.s. after treatment.

Non-responders Responders p value a
n 13 14
Age 56±9.6 46.9±6.7 0.003
Male (n, %) 4 (30.8) 7 (50) 0.440
Body mass index(kg/m2) before 26.4±3.5 23.7±2.2 0.002
after 27.3±4.3 24.5±3.0b 0.01
Waist circumference(cm) before 83.8±6.7 79. 3±6.8 0.035
after 84.6±7.3 82.3±8.0 NS
Hip circumference (cm) before 95.5±8.2 90.8±6.5 0.071
after 99.7±7.7b 96.1±7.3b 0.053
Waist-hip ratio before 0.88±0.04 0.87±0.04 NS
after 0.85±0.06 0.86±0.04 NS
Systolic blood pressure (mmHg) before 122±13 125±20 NS
after 122±12 120±10 NS
Diastolic blood pressure (mmHg) before 74±7 77±10 NS
after 77±7 82±7b NS
Fasting plasma glucose (mg/dl) before 123±44 181±68 0.044
after 117±26 130±41b NS
Fasting insulin (pmol/L) before 4.7±5.3 3.6±5.0 NS
after 6.4±6.8 5.5±4.7 NS
Hemoglobin A1c (%) before 8.1 ±1.5 11.1 ±2.3 0.004
after 7.1±1.1b 7.9±1.8b NS
Total Cholesterol (mmol/L) before 4.03±0.70 4.14 ±0.96 NS
after 4.59±0.67b 4.17±0.68 NS
Triglyceride (mmol/L) before 1.33±0.30 1.89±1.61 NS
after 1.52±0.41 1.69±0.70 NS
HDL-C (mmol/L) before 1.11±0.21 1.03 ±0.37 NS
after 1.42±0.37b 1.10±0.24b NS